Table 3.
Compliance with Breast Care Guideline and Timeliness of Resolution of Breast Problem
| Characteristic | Compliance with Breast Care Guideline, % | Adjusted* Odds Ratio for Compliance (95% Confidence Interval) | Adjusted* Hazard Ratio for Days Until Resolution of Breast Problem (95% Confidence Interval) |
|---|---|---|---|
| Eligibility criteria | |||
| Abnormal mammogram (n = 392) | 74.0† | 1.75 (1.16 to 2.64) | 1.07 (0.84 to 1.35) |
| Clinical breast complaint (n = 187) | 58.8 | — | — |
| Age, y | |||
| <50 (n = 293) | 63.8† | — | — |
| ≤50 (n = 286) | 74.5 | 1.58 (1.06 to 2.36) | 1.23 (1.01 to 1.51) |
| Race/ethnicity | |||
| White (n = 431) | 71.0 | — | — |
| African American (n = 84) | 59.5 | 0.67 (0.42 to 1.07)‡ | 0.92 (0.71 to 1.20)‡ |
| Hispanic (n = 33) | 75.8 | ||
| Other (n = 27) | 55.6 | ||
| Family history of breast cancer | |||
| Yes (n = 156) | 69.2 | 1.08 (0.70 to 1.67) | 1.01 (0.80 to 1.27) |
| No (n = 417) | 68.8 | — | — |
| Payer | |||
| Managed care (n = 348) | 73.3† | 1.72 (1.12 to 2.64) | 1.32 (1.05 to 1.67) |
| Other payer (n = 226) | 62.0 | — | — |
| Degree of worry | |||
| Not at all/a little worried (n = 469) | 70.2 | — | — |
| Very/somewhat worried (n = 110) | 64.6 | 0.79 (0.48 to 1.29) | 1.11 (0.84 to 1.46) |
| Radiologist's recommendation for further care based on index mammogram | |||
| Biopsy (n = 70) | 94.3† | 10.77 (3.71 to 31.25) | 3.69 (2.74 to 4.98) |
| Other (n = 509)§ | 65.7 | — | — |
| Site of primary care | |||
| A (n = 55) | 63.6‖ | — | — |
| B (n = 49) | 59.2 | 1.29 (0.54 to 3.11) | 1.15 (0.69 to 1.91) |
| C (n = 97) | 68.0 | 1.25 (0.58 to 2.69) | 0.99 (0.65 to 1.51) |
| D (n = 90) | 61.1 | 1.28 (0.60 to 2.74) | 1.01 (0.65 to 1.57) |
| E (n = 28) | 75.0 | 2.24 (0.75 to 6.70) | 1.49 (0.85 to 2.60) |
| F (n = 48) | 70.8 | 1.95 (0.79 to 4.81) | 1.20 (0.74 to 1.97) |
| G (n = 114) | 72.8 | 1.59 (0.72 to 3.53) | 1.21 (0.79 to 1.85) |
| H (n =80) | 83.8 | 4.03 (1.69 to 9.61) | 1.79 (1.17 to 2.75) |
| I (n = 18) | 55.6 | 1.28 (0.38 to 4.29) | 0.90 (0.43 to 1.90) |
*
Adjusted for age, family history of breast cancer, race, severity of mammographic abnormality, degree of worry about breast cancer, eligibility category, insurance status, and site of care.
†
P < .005 for comparison within characteristic.
‡
Comparison is for nonwhite compared with white patients.
§
Includes 6-month follow-up, 12-month (routine) follow-up, follow-up as clinically indicated.
‖
P < .05 for comparison within characteristic